GB0412602D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0412602D0
GB0412602D0 GBGB0412602.5A GB0412602A GB0412602D0 GB 0412602 D0 GB0412602 D0 GB 0412602D0 GB 0412602 A GB0412602 A GB 0412602A GB 0412602 D0 GB0412602 D0 GB 0412602D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0412602.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GBGB0412602.5A priority Critical patent/GB0412602D0/en
Publication of GB0412602D0 publication Critical patent/GB0412602D0/en
Priority to TW094117058A priority patent/TW200600086A/zh
Priority to EP05747241A priority patent/EP1756076B1/en
Priority to JP2007514127A priority patent/JP4860606B2/ja
Priority to ES05747241T priority patent/ES2347451T3/es
Priority to DE602005022859T priority patent/DE602005022859D1/de
Priority to US11/628,448 priority patent/US7745475B2/en
Priority to CNA2005800254863A priority patent/CN101018773A/zh
Priority to PCT/GB2005/002166 priority patent/WO2005121110A1/en
Priority to UAA200612279A priority patent/UA87685C2/ru
Priority to MXPA06014128A priority patent/MXPA06014128A/es
Priority to AT05747241T priority patent/ATE477249T1/de
Priority to KR1020067027324A priority patent/KR20070024650A/ko
Priority to EP08154684A priority patent/EP1992623A1/en
Priority to RU2006145204/04A priority patent/RU2403246C2/ru
Priority to CA002566951A priority patent/CA2566951A1/en
Priority to AU2005251990A priority patent/AU2005251990B2/en
Priority to BRPI0511808-5A priority patent/BRPI0511808A/pt
Priority to NZ551623A priority patent/NZ551623A/en
Priority to ARP050102265A priority patent/AR049139A1/es
Priority to MYPI20052532A priority patent/MY144048A/en
Priority to UY28936A priority patent/UY28936A1/es
Priority to SA05260154A priority patent/SA05260154B1/ar
Priority to IL179389A priority patent/IL179389A0/en
Priority to ZA200610140A priority patent/ZA200610140B/xx
Priority to NO20070032A priority patent/NO20070032L/no
Priority to HK07106859.0A priority patent/HK1102091A1/xx
Priority to US12/336,170 priority patent/US20090253676A1/en
Ceased legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GBGB0412602.5A 2004-06-05 2004-06-05 Compounds Ceased GB0412602D0 (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
GBGB0412602.5A GB0412602D0 (en) 2004-06-05 2004-06-05 Compounds
TW094117058A TW200600086A (en) 2004-06-05 2005-05-25 Chemical compound
NZ551623A NZ551623A (en) 2004-06-05 2005-06-01 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
KR1020067027324A KR20070024650A (ko) 2004-06-05 2005-06-01 당뇨병 치료에 있어서 ｇｌｋ 활성화제로서 사용하기 위한헤테로아릴 벤즈아미드 유도체
CA002566951A CA2566951A1 (en) 2004-06-05 2005-06-01 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
ES05747241T ES2347451T3 (es) 2004-06-05 2005-06-01 Derivados de heteroaril benzamida para uso como activadores de glk en el tratamiento de la diabetes.
DE602005022859T DE602005022859D1 (de) 2004-06-05 2005-06-01 Heteroarylbenzamidderivate zur verwendung als glk-aktivatoren bei der behandlung von diabetes
US11/628,448 US7745475B2 (en) 2004-06-05 2005-06-01 Heteroaryl benzamide derivatives as GLK activators
CNA2005800254863A CN101018773A (zh) 2004-06-05 2005-06-01 在糖尿病治疗中用作glk激活剂的杂芳基苯甲酰胺衍生物
PCT/GB2005/002166 WO2005121110A1 (en) 2004-06-05 2005-06-01 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
UAA200612279A UA87685C2 (ru) 2004-06-05 2005-06-01 Производные гетероарилбензамида для применения как активаторов glk в лечении диабета
MXPA06014128A MXPA06014128A (es) 2004-06-05 2005-06-01 Derivados de heteroaril-benzamida para utilizarse como activadores de glk en el tratamiento de diabetes.
AT05747241T ATE477249T1 (de) 2004-06-05 2005-06-01 Heteroarylbenzamidderivate zur verwendung als glk-aktivatoren bei der behandlung von diabetes
EP05747241A EP1756076B1 (en) 2004-06-05 2005-06-01 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
EP08154684A EP1992623A1 (en) 2004-06-05 2005-06-01 Heteroaryl benzamide derivative for use as GLK activator in the treatment of diabetes
RU2006145204/04A RU2403246C2 (ru) 2004-06-05 2005-06-01 Гетероарилбензамидные производные для применения в качестве активаторов глюкокиназы (glk) в лечении диабета
JP2007514127A JP4860606B2 (ja) 2004-06-05 2005-06-01 糖尿病の処置にｇｌｋアクチベーターとして用いるためのヘテロアリールベンズアミド誘導体
AU2005251990A AU2005251990B2 (en) 2004-06-05 2005-06-01 Hetroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
BRPI0511808-5A BRPI0511808A (pt) 2004-06-05 2005-06-01 composto ou um sal, pró-droga ou solvato do mesmo, uso de um composto método para tratar doenças mediadas com glk, e, processo para a preparação de um composto
UY28936A UY28936A1 (es) 2004-06-05 2005-06-02 Grupo de compuestos benzoil-amino-heterociclilo y composiciones farmaceuticas que los comprenden, utiles para tratamiento de enfermedades mediadas por glucoquinasa (gq)
ARP050102265A AR049139A1 (es) 2004-06-05 2005-06-02 Compuestos derivados de benzamidas n - heterociclil - sustituidas como activadores de la glucoquinasa (glk), metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso como medicamento en el tratamiento de la diabetes tipo ii.
MYPI20052532A MY144048A (en) 2004-06-05 2005-06-02 Chemical compound
SA05260154A SA05260154B1 (ar) 2004-06-05 2005-06-04 مشتقات أريل بنزاميد غير متجانسة مفيدة كمنشطات لـ glk في علاج مرض السكر
IL179389A IL179389A0 (en) 2004-06-05 2006-11-19 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
ZA200610140A ZA200610140B (en) 2004-06-05 2006-12-04 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
NO20070032A NO20070032L (no) 2004-06-05 2007-01-03 Hetroarylbenzamid-derivater for anvendelse som GLK-aktivatorer ved behandling av diabetes
HK07106859.0A HK1102091A1 (en) 2004-06-05 2007-06-27 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
US12/336,170 US20090253676A1 (en) 2004-06-05 2008-12-16 Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of Diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0412602.5A GB0412602D0 (en) 2004-06-05 2004-06-05 Compounds

Publications (1)

Publication Number Publication Date
GB0412602D0 true GB0412602D0 (en) 2004-07-07

Family

ID=32696738

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0412602.5A Ceased GB0412602D0 (en) 2004-06-05 2004-06-05 Compounds

Country Status (4)

Country Link
CN (1) CN101018773A (ru)
GB (1) GB0412602D0 (ru)
UA (1) UA87685C2 (ru)
ZA (1) ZA200610140B (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120277208A1 (en) * 2009-12-11 2012-11-01 Astellas Pharma Inc. Benzamide compound

Also Published As

Publication number Publication date
CN101018773A (zh) 2007-08-15
UA87685C2 (ru) 2009-08-10
ZA200610140B (en) 2009-03-25

Similar Documents

Publication Publication Date Title
GB0405933D0 (en) Compounds
EP1737831A4 (en) NEUROLOGICALLY ACTIVE COMPOUNDS
GB0405937D0 (en) Compounds
EP1755617A4 (en) PERFLUORCARBON-SOLUBLE COMPOUNDS
GB0405193D0 (en) Compounds
GB0405267D0 (en) Compounds
GB0405101D0 (en) Compounds
GB0401269D0 (en) Compounds
GB0408772D0 (en) Compounds
GB0405280D0 (en) Compounds
ZA200606475B (en) Compounds
GB0405893D0 (en) Compounds
GB0403593D0 (en) Compounds
GB0406916D0 (en) Compounds
GB0412602D0 (en) Compounds
GB0403334D0 (en) Compounds
GB0406963D0 (en) Compounds
GB0401657D0 (en) Compounds
GB0403267D0 (en) Compounds
GB0403594D0 (en) Compounds
GB0401656D0 (en) Compounds
GB0401654D0 (en) Compounds
GB0405194D0 (en) Compounds
GB0405198D0 (en) Compounds
GB0401653D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)